Table 3.

Presenting glucose as a predictor for clinical outcomes in patients with GCS ≤8 (n = 28).

Hyperglycemia defined as glucose >200 mg/dL (11.1 mmol/L)	EDa normoglycemia (n = 13)	EDa hyperglycemia (n = 15)	p values
Death, n (%)	2 (15)	7 (47)	0.077
28 hospital-free days, median (IQRb)	5 (0–23)	10 (0–23)	0.587
14 pediatric intensive care unit-free days, median (IQRb)	7 (0–12)	5 (2–10)	0.815
14 ventilation-free days, median (IQRb)	8 (0–13)	7 (2–10)	0.889
Hyperglycemia defined as glucose >150 mg/dL (8.3 mmol/L)	EDa normoglycemia (n = 9)	EDa hyperglycemia (n = 19)	p values
Death, n (%)	2 (22)	7 (37)	0.439
28 hospital-free days, median (IQRb)	5 (0–7)	10 (0–23)	0.668
14 pediatric intensive care unit-free days, median (IQRb)	7 (0–8)	5 (0–10)	0.960
14 ventilation-free days, median (IQRb)	8 (0–9)	7 (2–11)	0.901

^aED: emergency department; ^bIQR: interquartile range.